Adipogenic potential of skeletal muscle satellite cells

Future Lipidology

Volumn 4, Issue 2, 2009, Pages 245-265

  Sanna, Marta ^a   Franzin, Chiara ^a   Pozzobon, Michela ^a   Rossi, Carlo Alberto ^a   Calcagno, Alessandra ^a   Scarda, Alessandro ^a   Dal Prà, Chiara ^a   Pilon, Catia ^a   Milan, Gabriella ^a   Federspil, Giovanni ^a   De Coppi, Paolo ^a,b   Vettor, Roberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Adipogenesis; Adipogenic differentiation; Myogenesis; Satellite cell; Skeletal muscle; Stem cell

Indexed keywords

ADIPONECTIN; CADHERIN; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; CD34 ANTIGEN; CONNEXIN 43; LEPTIN; MYOD PROTEIN; MYOGENIC FACTOR; MYOGENIC FACTOR 5; MYOGENIC FACTOR 6; MYOGENIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN WNT10B; REACTIVE OXYGEN METABOLITE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRANSCRIPTION FACTOR PAX7; UNCLASSIFIED DRUG; WNT PROTEIN;

ADIPOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL HETEROGENEITY; CELL STIMULATION; CELL TRANSPLANTATION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; METABOLIC DISORDER; MUSCLE ATROPHY; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE METABOLISM; MUSCLE REGENERATION; NERVE CELL PLASTICITY; NEUROMUSCULAR DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SKELETAL MUSCLE SATELLITE CELL;

EID: 67249121383     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/CLP.09.8     Document Type: Review

References (143)

1. Bogardus C, Lillioja S, Mott D, Reaven GR, Kashiwagi A, Foley JE: Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. J. Clin. Invest. 73, 800-805 (1984).
2. He J, Kelley DE: Muscle glycogen content in Type 2 diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 287, E1002-E1007 (2004).
3. Kelley DE, Goodpaster BH: Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24, 933-941 (2001).
4. Machann J, Haring H, Schick F, Stumvoll M: Intramyocellular lipids and insulin resistance. Diabetes Obes. Metab. 6, 239-248 (2004).
5. Bonen A, Parolin ML, Steinberg GR et al.: Triacylglycerol accumulation in human obesity and Type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J. 18, 1144-1146 (2004).
6. Kelley DE, Goodpaster B, Wing RR, Simoneau JA: Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am. J. Physiol. 277, E1130-E1141 (1999).
7. Kelley DE, Reilly JP, Veneman T, Mandarino LJ: Effects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans. Am. J. Physiol. 258, E923-E929 (1990).
8. Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE: Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J. 13, 2051-2060 (1999).
9. Greco AV, Mingrone G, Giancaterini A et al.: Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51, 144-151 (2002).
10. Hegarty BD, Furler SM, Ye J, Cooney GJ, Kraegen EW: The role of intramuscular lipid in insulin resistance. Acta Physiol. Scand. 178, 373-383 (2003).
11. Kohrt WM, Holloszy JO: Loss of skeletal muscle mass with aging: effect on glucose tolerance. J. Gerontol. A Biol. Sci. Med. Sci. 50 Spec. No, 68-72 (1995).
12. Goodpaster BH, Thaete FL, Kelley DE: Thigh adipose tissue distribution is associated with insulin resistance in obesity and in Type 2 diabetes mellitus. Am. J. Clin. Nutr. 71, 885-892 (2000).
13. Hegele RA: Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome. Mol. Genet. Metab. 71, 539-544 (2000).
14. Driscoll SD, Meininger GE, Ljungquist K et al.: Differential effects of metformin and exercise on muscle adiposity and metabolic indices in human immunodeficiency virus-infected patients. J. Clin. Endocrinol. Metab. 89, 2171-2178 (2004).
15. Mauro A: Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 9, 493-495 (1961).
16. Asakura A, Komaki M, Rudnicki M: Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68, 245-253 (2001).
17. Zammit PS, Partridge TA, Yablonka-Reuveni Z: The skeletal muscle satellite cell: the stem cell that came in from the cold. J. Histochem. Cytochem. 54, 1177-1191 (2006).
18. Kuang S, Rudnicki MA: The emerging biology of satellite cells and their therapeutic potential. Trends Mol. Med. 14, 82-91 (2008).
19. Lajtha LG: Haemopoietic stem cells: concept and definitions. Blood Cells 5, 447-455 (1979).
20. Fuchs E, Segre JA: Stem cells: a new lease on life. Cell 100, 143-155 (2000).
21. Oreffo RO, Cooper C, Mason C, Clements M: Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential. Stem Cell Rev. 1, 169-178 (2005).
22. Shefer G, M Wleklinski-Lee, Yablonka-Reuveni Z: Skeletal muscle satellite cells can spontaneously enter an alternative mesenchymal pathway. J. Cell Sci. 117, 5393-5404 (2004).
23. Collins CA, Olsen I, Zammit PS et al.: Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122, 289-301 (2005).
24. De Coppi P, Milan G, Scarda A et al.: Rosiglitazone modifies the adipogenic potential of human muscle satellite cells. Diabetologia 49, 1962-1973 (2006).
25. Kuang S, Kuroda K, Le Grand F, Rudnicki MA: Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell 129, 999-1010 (2007).
26. Schultz E, Gibson MC, Champion T: Satellite cells are mitotically quiescent in mature mouse muscle: an EM and radioautographic study. J. Exp. Zool. 206, 451-456 (1978).
27. Hawke TJ, Garry DJ: Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 91, 534-551 (2001).
28. Moss FP, Leblond CP: Satellite cells as the source of nuclei in muscles of growing rats. Anat. Rec. 170, 421-435 (1971).
29. Schultz E: Satellite cell proliferative compartments in growing skeletal muscles. Dev. Biol. 175, 84-94 (1996).
30. Zammit PS, Golding JP, Nagata Y, Hudon V, Partridge TA, Beauchamp JR: Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? J. Cell Biol. 166, 347-357 (2004).
31. Charge SB, Rudnicki MA: Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84, 209-238 (2004).
32. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA: Pax7 is required for the specification of myogenic satellite cells. Cell 102, 777-786 (2000).
33. Oustanina S, Hause G, Braun T: Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification. EMBO J. 23, 3430-3439 (2004).
34. Kuang S, Charge SB, Seale P, Huh M, Rudnicki MA: Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis. J. Cell Biol. 172, 103-113 (2006).
35. Relaix F, Montarras D, Zaffran S et al.: Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells. J. Cell Biol. 172, 91-102 (2006).
36. Yablonka-Reuveni Z, Rivera AJ: Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers. Dev. Biol. 164, 588-603 (1994).
37. + adult stem cells during muscle regeneration. Cell 113, 841-852 (2003).
38. + stem cells from injured muscle. PLoS Biol. 2, E130 (2004).
39. Tapscott SJ, Lassar AB, Davis RL, Weintraub H: 5-bromo-2′-deoxyuridine blocks myogenesis by extinguishing expression of MyoD1. Science 245, 532-536 (1989).
40. Asakura A, Hirai H, Kablar B et al.: Increased survival of muscle stem cells lacking the MyoD gene after transplantation into regenerating skeletal muscle. Proc. Natl Acad. Sci. USA 104, 16552-16557 (2007).
41. Martin JF, Li L, Olson EN: Repression of myogenin function by TGF-β 1 is targeted at the basic helix-loop-helix motif and is independent of E2A products. J. Biol. Chem. 267, 10956-10960 (1992).
42. Fuchtbauer EM, Westphal H: MyoD and myogenin are coexpressed in regenerating skeletal muscle of the mouse. Dev. Dyn. 193, 34-39 (1992).
43. Cooper RN, Tajbakhsh S, Mouly V, Cossu G, Buckingham M, Butler-Browne GS: In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J. Cell Sci. 112(Pt 17), 2895-2901 (1999).
44. -/-satellite cells in single-fiber culture are differentiation defective and MRF4 deficient. Dev. Biol. 224, 122-137 (2000).
45. Megeney LA, Kablar B, Garrett K, Anderson JE, Rudnicki MA: MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 10, 1173-1183 (1996).
46. Smith TH, Block NE, Rhodes SJ, Konieczny SF, Miller JB: A unique pattern of expression of the four muscle regulatory factor proteins distinguishes somitic from embryonic, fetal and newborn mouse myogenic cells. Development 117, 1125-1133 (1993).
47. Rawls A, Wilson-Rawls J, Olson EN: Genetic regulation of somite formation. Curr. Top Dev. Biol. 47, 131-154 (2000).
48. Brunetti A, Goldfine ID: Role of myogenin in myoblast differentiation and its regulation by fibroblast growth factor. J. Biol. Chem. 265, 5960-5963 (1990).
49. Rhodes SJ, Konieczny SF: Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev. 3, 2050-2061 (1989).
50. Kassar-Duchossoy L, Gayraud-Morel B, Gomes D et al.: Mrf4 determines skeletal muscle identity in Myf5: Myod double-mutant mice. Nature 431, 466-471 (2004).
51. Krause DS, Fackler MJ, Civin CI, May WS: CD34: structure, biology, and clinical utility. Blood 87, 1-13 (1996).
52. Suda J, Sudo T, Ito M, Ohno N, Yamaguchi Y, Suda T: Two types of murine CD34 mRNA generated by alternative splicing. Blood 79, 2288-2295 (1992).
53. Nakamura Y, Komano H, Nakauchi H: Two alternative forms of cDNA encoding CD34. Exp. Hematol. 21, 236-242 (1993).
54. Irintchev A, Zeschnigk M, Starzinski-Powitz A, Wernig A: Expression pattern of M-cadherin in normal, denervated, and regenerating mouse muscles. Dev. Dyn. 199, 326-337 (1994).
55. Garry DJ, Yang Q, Bassel-Duby R, Williams RS: Persistent expression of MNF identifies myogenic stem cells in postnatal muscles. Dev. Biol. 188, 280-294 (1997).
56. Garry DJ, Meeson A, Elterman J et al.: Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF. Proc. Natl Acad. Sci. USA 97, 5416-5421 (2000).
57. Rouger K, Brault M, Daval N et al.: Muscle satellite cell heterogeneity: in vitro and in vivo evidences for populations that fuse differently. Cell Tissue Res. 317, 319-326 (2004).
58. LaBarge MA, Blau HM: Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111, 589-601 (2002).
59. Heslop L, Morgan JE, Partridge TA: Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J. Cell Sci. 113 (Pt 12), 2299-2308 (2000).
60. Hashimoto N, Kiyono T, Wada MR et al.: Osteogenic properties of human myogenic progenitor cells. Mech. Dev. 125, 257-269 (2008).
61. Yada E, Yamanouchi K, Nishihara M: Adipogenic potential of satellite cells from distinct skeletal muscle origins in the rat. J. Vet. Med. Sci. 68, 479-486 (2006).
62. Gregoire FM, Smas CM, Sul HS: Understanding adipocyte differentiation. Physiol. Rev. 78, 783-809 (1998).
63. Gregoire FM: Adipocyte differentiation: from fibroblast to endocrine cell. Exp. Biol. Med. (Maywood) 226, 997-1002 (2001).
64. Rosen ED, MacDougald OA: Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 7, 885-896 (2006).
65. Farmer SR: Transcriptional control of adipocyte formation. Cell Metab. 4, 263-273 (2006).
66. Gesta S, Tseng YH, Kahn CR: Developmental origin of fat: tracking obesity to its source. Cell 131, 242-256 (2007).
67. Pairault J, Green H: A study of the adipose conversion of suspended 3T3 cells by using glycerophosphate dehydrogenase as differentiation marker. Proc. Natl Acad. Sci. USA 76, 5138-5142 (1979).
68. Umek RM, Friedman AD, McKnight SL: CCAAT-enhancer binding protein: a component of a differentiation switch. Science 251, 288-292 (1991).
69. Altiok S, Xu M, Spiegelman BM: PPAR-γ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev. 11, 1987-1998 (1997).
70. Rubin CS, Hirsch A, Fung C, Rosen OM: Development of hormone receptors and hormonal responsiveness in vitro. Insulin receptors and insulin sensitivity in the preadipocyte and adipocyte forms of 3T3-L1 cells. J. Biol. Chem. 253, 7570-7578 (1978).
71. Deslex S, Negrel R, Ailhaud G: Development of a chemically defined serum-free medium for differentiation of rat adipose precursor cells. Exp. Cell Res. 168, 15-30 (1987).
72. Gregoire F, Todoroff G, Hauser N, Remacle C: The stroma-vascular fraction of rat inguinal and epididymal adipose tissue and the adipoconversion of fat cell precursors in primary culture. Biol. Cell 69, 215-222 (1990).
73. Tang QQ, Gronborg M, Huang H et al.: Sequential phosphorylation of CCAAT enhancer-binding protein β by MAPK and glycogen synthase kinase 3β is required for adipogenesis. Proc. Natl Acad. Sci. USA 102, 9766-9771 (2005).
74. Qiu Z, Wei Y, Chen N, Jiang M, Wu J, Liao K: DNA synthesis and mitotic clonal expansion is not a required step for 3T3-L1 preadipocyte differentiation into adipocytes. J. Biol. Chem. 276, 11988-11995 (2001).
75. Spiegelman BM, Farmer SR: Decreases in tubulin and actin gene expression prior to morphological differentiation of 3T3 adipocytes. Cell 29, 53-60 (1982).
76. Weiner FR, Shah A, Smith PJ, Rubin CS, Zern MA: Regulation of collagen gene expression in 3T3-L1 cells. Effects of adipocyte differentiation and tumor necrosis factor α. Biochemistry 28, 4094-4099 (1989).
77. Havel, PJ: Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53 (Suppl. 1), S143-S151 (2004).
78. Trayhurn P: Endocrine and signaling role of adipose tissue: new perspectives on fat. Acta Physiol. Scand. 184, 285-293 (2005).
79. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7, 947-953 (2001).
80. Yamauchi T, Kamon J, Waki H et al.: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941-946 (2001).
81. Ouchi N, Kihara S, Arita Y et al.: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100, 2473-2476 (1999).
82. Ouchi N, Kihara S, Arita Y et al.: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 102, 1296-1301 (2000).
83. Ouchi N, Kihara S, Arita Y et al.: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103, 1057-1063 (2001).
84. Rosen ED, Hsu CH, Wang X et al.: C/EBP-α induces adipogenesis through PPAR-γ: a unified pathway. Genes Dev. 16, 22-26 (2002).
85. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPAR-γ 2, a lipid-activated transcription factor. Cell 79, 1147-1156 (1994).
86. Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J. Lipid Res. 48, 1253-1262 (2007).
87. Clevers H: Wnt/β-catenin signaling in development and disease. Cell 127, 469-480 (2006).
88. Prestwich TC, Macdougald OA: Wnt/β-catenin signaling in adipogenesis and metabolism. Curr. Opin. Cell Biol. 19, 612-617 (2007).
89. Ross SE, Hemati N, Longo KA et al.: Inhibition of adipogenesis by Wnt signaling. Science 289, 950-953 (2000).
90. Moldes M, Zuo Y, Morrison RF et al.: Peroxisome-proliferator-activated receptor γ suppresses Wnt/ β-catenin signaling during adipogenesis. Biochem. J. 376, 607-613 (2003).
91. Wang, Pattabiraman N, Zhou JN et al.: Cyclin D1 repression of peroxisome proliferator-activated receptor γ expression and transactivation. Mol. Cell Biol. 23, 6159-6173 (2003).
92. Fu M, Rao M, Bouras T et al.: Cyclin D1 inhibits peroxisome proliferator-activated receptor γ-mediated adipogenesis through histone deacetylase recruitment. J. Biol. Chem. 280, 16934-16941 (2005).
93. Christodoulides C, Scarda A, Granzotto M et al.: WNT10B mutations in human obesity. Diabetologia 49, 678-684 (2006).
94. Teboul L, Gaillard D, Staccini L, Inadera H, Amri EZ, Grimaldi PA: Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells. J. Biol. Chem. 270, 28183-28187 (1995).
95. Hu E, Tontonoz P, Spiegelman BM: Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR-γ and C/EBP-α. Proc. Natl Acad. Sci. USA 92, 9856-9860 (1995).
96. Grimaldi PA, Teboul L, Inadera H, Gaillard D, Amri EZ: Trans-differentiation of myoblasts to adipoblasts: triggering effects of fatty acids and thiazolidinediones. Prostaglandins Leukot. Essent. Fatty Acids 57, 71-75 (1997).
97. Holst D, Luquet S, Kristiansen K, Grimaldi PA: Roles of peroxisome proliferator-activated receptors δ and γ in myoblast transdifferentiation. Exp. Cell Res. 288, 168-176 (2003).
98. Seale P, Bjork B, Yang W et al.: PRDM16 controls a brown fat/ skeletal muscle switch. Nature 454,961-967 (2008).
99. Rando TA, Blau HM: Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125, 1275-1287 (1994).
100. Cornelison DD, Wold BJ: Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 191, 270-283 (1997).
101. Kausch C, Krutzfeldt J, Witke A et al.: Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells. Biochem. Biophys. Res. Commun. 280, 664-674 (2001).
102. Singh NK, Chae HS, Hwang IH et al.: Transdifferentiation of porcine satellite cells to adipoblasts with ciglitizone. J. Anim. Sci. 85, 1126-1135 (2007).
103. Kook SH, Choi KC, Son YO et al.: Satellite cells isolated from adult Hanwoo muscle can proliferate and differentiate into myoblasts and adipose-like cells. Mol. Cell 22, 239-245 (2006).
104. Gibson MC, Schultz E: Age-related differences in absolute numbers of skeletal muscle satellite cells. Muscle Nerve 6, 574-580 (1983).
105. Shefer G, Van de Mark DP, Richardson JB, Yablonka-Reuveni Z: Satellite-cell pool size does matter: defining the myogenic potency of aging skeletal muscle. Dev. Biol. 294, 50-66 (2006).
106. Schultz E, Lipton BH: Skeletal muscle satellite cells: changes in proliferation potential as a function of age. Mech. Ageing Dev. 20, 377-383 (1982).
107. Johnson SE, Allen RE: Proliferating cell nuclear antigen (PCNA) is expressed in activated rat skeletal muscle satellite cells. J. Cell Physiol. 154, 39-43 (1993).
108. Taylor-Jones JM, McGehee RE, Rando TA, Lecka-Czernik B, Lipschitz DA, Peterson CA: Activation of an adipogenic program in adult myoblasts with age. Mech. Ageing Dev. 123, 649-661 (2002).
109. Vertino AM, Taylor-Jones JM, Longo KA et al.: Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts. Mol. Biol. Cell 16, 2039-2048 (2005).
110. Yamanouchi K, Yada E, Ishiguro N, Nishihara M: 18α-glycyrrhetinic acid induces phenotypic changes of skeletal muscle cells to enter adipogenesis. Cell Physiol. Biochem. 20, 781-790 (2007).
111. Bryan BA, Mitchell DC, Zhao L et al.: Modulation of muscle regeneration, myogenesis, and adipogenesis by the Rho family guanine nucleotide exchange factor GEFT. Mol. Cell Biol. 25, 11089-11101 (2005).
112. Sordella R, Jiang W, Chen GC, Curto M, Settleman J: Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis. Cell 113, 147-158 (2003).
113. Pisani DF, Coldefy AS, Elabd C et al.: Involvement of BTBD1 in mesenchymal differentiation. Exp. Cell Res. 313, 2417-2426 (2007).
114. Csete M, Walikonis J, Slawny N et al.: Oxygen-mediated regulation of skeletal muscle satellite cell proliferation and adipogenesis in culture. J. Cell Physiol. 189, 189-196 (2001).
115. Guillet-Deniau I, Pichard AL, Kone A et al.: Glucose induces de novo lipogenesis in rat muscle satellite cells through a sterol-regulatory-element-binding-protein-1c-dependent pathway. J. Cell Sci. 117, 1937-1944 (2004).
116. Aguiari P, Leo S, Zavan B et al.: High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc. Natl Acad. Sci. USA 105, 1226-1231 (2008).
117. Peterson JM, Bryner RW, Alway SE: Satellite cell proliferation is reduced in muscles of obese Zucker rats but restored with loading. Am. J. Physiol. Cell Physiol. 295, C521-C528 (2008).
118. Scherer PE: Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55, 1537-1545 (2006).
119. Ceddia RB: Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis. Int. J. Obes. (Lond.) 29, 1175-1183 (2005).
120. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ: Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389, 374-377 (1997).
121. Ceddia RB, William WN Jr, Curi R: Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: evidence for an effect of leptin onglucose uptake and decarboxylation. Int. J. Obes. Relat. Metab. Disord. 23,75-82 (1999).
122. Bates SH, Gardiner JV, Jones RB, Bloom SR, Bailey CJ: Acute stimulation of glucose uptake by leptin in l6 muscle cells. Horm. Metab. Res. 34, 111-115 (2002).
123. Bortoluzzi S, Scannapieco P, Cestaro A, Danieli GA, Schiaffino S: Computational reconstruction of the human skeletal muscle secretome. Proteins 62, 776-792 (2006).
124. Grobet L, Martin LJ, Poncelet D et al.: A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat. Genet. 17, 71-74 (1997).
125. McPherron AC, Lawler AM, Lee SJ: Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 387, 83-90 (1997).
126. Lin J, Arnold HB, Della-Fera MA, Azain MJ, Hartzell DL, Baile CA: Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem. Biophys. Res. Commun. 291, 701-706 (2002).
127. McPherron AC, Lee SJ: Suppression of body fat accumulation in myostatin-deficient mice. J. Clin. Invest. 109, 595-601 (2002).
128. Milan G, Dalla Nora E, Pilon C et al.: Changes in muscle myostatin expression in obese subjects after weight loss. J. Clin. Endocrinol. Metab. 89, 2724-2727 (2004).
129. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R: MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75, 1351-1359 (1993).
130. Dulor JP, Cambon B, Vigneron P et al.: Expression of specific white adipose tissue genes in denervation-induced skeletal muscle fatty degeneration. FEBS Lett. 439, 89-92 (1998).
131. Solomon AM, Bouloux PM: Modifying muscle mass - the endocrine perspective. J. Endocrinol. 191, 349-360 (2006).
132. Lynch GS, Schertzer JD, Ryall JG: Therapeutic approaches for muscle wasting disorders. Pharmacol. Ther. 113, 461-487 (2007).
133. Banker B, Engel A: Ultrastructural changes in diseased muscle. In: Myology. Engel A, Franzini-Armstrong C (Eds). McGraw-Hill, Inc., NY, USA 720-721 (2004).
134. Goodpaster BH, Krishnaswami S, Resnick H et al.: Association between regional adipose tissue distribution and both Type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 26, 372-379 (2003).
135. Goodpaster BH, Krishnaswami S, Harris TB et al.: Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch. Intern. Med. 165,777-783 (2005).
136. Garg A, Peshock RM, Fleckenstein JL: Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J. Clin. Endocrinol. Metab. 84, 170-174 (1999).
137. Torriani M, Hadigan C, Jensen ME, Grinspoon S: Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome. J. Appl. Physiol. 95, 1005-1010 (2003).
138. Luzi L, Perseghin G, Tambussi G et al.: Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy. Am. J. Physiol. Endocrinol. Metab. 284, E274-E280 (2003).
139. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820 (2001).
140. Wagatsuma A: Upregulation of gene encoding adipogenic transcriptional factors C/EBP-α and PPAR-γ2 in denervated muscle. Exp. Physiol. 91, 747-753 (2006).
141. Akimoto T, Ushida T, Miyaki S et al.: Mechanical stretch inhibits myoblast-to-adipocyte differentiation through Wnt signaling. Biochem. Biophys. Res. Commun. 329,381-385 (2005).
142. Liu K, Guan Y, MacNicol MC, MacNicol AM, McGehee RE Jr: Early expression of p107 is associated with 3T3-L1 adipocyte differentiation. Mol. Cell Endocrinol. 194, 51-61 (2002).
143. Guan Y, Taylor-Jones JM, Peterson CA, McGehee RE Jr: p130/p107 expression distinguishes adipogenic potential in primary myoblasts based on age. Biochem. Biophys. Res. Commun. 296, 1340-1345 (2002).